Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 128312-11-8 | MDL No. : | MFCD01319105 |
Formula : | C7H9BO2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | TYVPOLHSKGEXIH-UHFFFAOYSA-N |
M.W : | 168.02 | Pubchem ID : | 2734383 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 47.99 |
TPSA : | 65.76 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.37 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.34 |
Log Po/w (WLOGP) : | 0.09 |
Log Po/w (MLOGP) : | 0.88 |
Log Po/w (SILICOS-IT) : | -0.2 |
Consensus Log Po/w : | 0.42 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.0 |
Solubility : | 1.69 mg/ml ; 0.0101 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.32 |
Solubility : | 0.799 mg/ml ; 0.00476 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.78 |
Solubility : | 2.79 mg/ml ; 0.0166 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.03 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With sodium hydroxide; iodine; magnesium In tetrahydrofuran | PREPARATION 101 3-Methylthiophenylboronic Acid A solution of 3-bromothioanisole (10.3 g, 50.9 mmol) in anhydrous tetrahydrofuran (15 ml) was added dropwise to a stirred mixture of magnesium turnings (1.86 g, 75 mmol) and a crystal of iodine under nitrogen. Once the reaction was initiated, the remainder of the solution was added at such a rate as to keep the reaction mixture under reflux. When the addition was complete, the mixture was stirred under reflux for a further 1 hour, allowed to cool to room temperature and then added to a solution of trimethyl borate (5.8 ml, 51 mmol) in anhydrous tetrahydrofuran (25 ml), whilst keeping the internal temperature at about -10° C. The reaction mixture was allowed to warm to about 0° C., stirred for 30 minutes and then quenched with 2M hydrochloric acid. The resulting mixture was extracted with ether, then the combined extracts extracted, in turn, with 2M aqueous sodium hydroxide solution. The combined aqueous extracts were acidified with concentrated hydrochloric acid and extracted with ether. The combined ether extracts were dried (MgSO4) and evaporated under reduced pressure to provide the title compound (7.8 g, 100percent) as a white solid. δ(DMSOd6): 2.45 (s,3H), 7.27 (m,2H), 7.54 (m,1H), 7.67 (s,1H), 8.05 (brs,2H), |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With potassium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; water; at 150℃; for 0.333333h;Microwave; | A solution of 4-Chloro-2-(2-hydroxy-l-hydroxymethyl-ethylamino)-8- (2 ,4-difluoro-phenyl)-8H-pyrido [2 ,3-d] pyrimidin-7-one (50mg, 0.13mmol) in dioxane / H2O (3 : 1, 4.8mL) was mixed with 3- methylthiophenyl boronic acid (33.8mg, 0.20mmol) and K2CO3 (54.3mg, 0.39mmol). The resultant mixture was bubbled with argon for 5 minutes follwoed by the addition of Pd(PPh3 )4 (3.0mg, 0.0026mmol). The reaction tube was sealed and heated with "Smith Creator" (microwave, 15O0C) for 15minutes. The mixture was concentrated under vaco. Flash chromatography (EtOAc / Hexane, 3 : 1) then provided the title compound (90%): MS (ES) m/z All (M+H)+; 1H-NMR(CDCl3) delta 2.40 (s, br, 2H), 2.40 (s, 3H), 3.90 (m, br, 5H), 6.00 (m, br, IH), 6.45 (m, IH), 7.15 (m, 2H), 7.40 (m, 5H), 7.85 (m, IH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With cesium fluoride;palladium diacetate; johnphos; In tetrahydrofuran; for 8h;Heating / reflux; | Example 29: Methyl (S)-{4-(3'-methylsulfonylbiphenyl-4-yl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl}acetate A mixture of the compound described in Example 1 (1.66 g), palladium acetate (44 mg), 2-(di-tert-butylphosphino)biphenyl (120 mg), cesium fluoride (1.82 g) and <strong>[128312-11-8]3-methylthiophenylboronic acid</strong> (1 g) was heated under reflux for 8 hr in tetrahydrofuran (10 mL). After cooling, water was added, and the mixture was extracted with chloroform. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was evaporated and the residue was purified by column chromatography (chloroform:methanol=100:1) to give methyl (S)-{4-(3'-methylthiobiphenyl-4-yl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl}acetate (2 g). The obtained compound (2 g) was dissolved in a mixture of methanol (40 mL) and water (4 mL). Sodium bicarbonate (1 g) and oxone (4.9 g) were successively added thereto, and the mixture was stirred at room temperature for 3 hr. After completion of the reaction, water was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was evaporated and the residue was purified by column chromatography (chloroform:methanol=100:1) to give the title compound (2 g). 1H-NMR (400 MHz, DMSO-d6) delta: 1.68 (3H, s), 2.44 (3H, s), 2.63 (3H, s), 3.31 (3H, s), 3.45 (1H, dd, J=16.8, 7.2 Hz), 3.52 (1H, dd, J=16.8 7.2 Hz), 3.69 (3H, s), 4.53 (1H, t, J=7.2 Hz), 7.56 (2H, d, J=8.0 Hz), 7.77 (1H, t, J=8.0 Hz), 7.84 (2H, t, J=8.0 Hz), 7.95 (1H, d, J=8.0 Hz), 8.07 (1H, d, J=8.0 Hz), 8.19 (1H, s) MS (ESI) m/z: 535 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,2-dimethoxyethane; water; at 80℃; for 12h; | Example 17: 3-[4-(1 ,1 -dimethylethyl)phenyl]-1 -[4-methyl-3'-(methylthio)-3- biphenylyl]methyl}-1 H-indole-2-carboxylic acid <n="105"/>To 150 mg (0.30 mmol) of ethyl 1 -(5-bromo-2-methylbenzyl)-3-(4-te/t- butylphenyl)-1 H-indole-2-carboxylate (intermediate 10) in 1.5 ml_ DME was added 75 mg (0.45 mmol) <strong>[128312-11-8][3-(methylthio)phenyl]boronic acid</strong>, 7 mg (0.02 mmol) Pd(PPh3)4 and 450 uL (0.89 mmol) 2.0 M Na2CO3 (aq) then the mixture was stirred at 8O0C for 12 hr. The solution was filtered through a plug of Celite and the plug washed with 20 ml_ EtOAc. The combined organics were washed with 20 ml_ H2O and 20 ml_ brine then concentrated and purified by silica gel chromatography (12 grams of silica gel eluting with 0-30% EtOAc in hexanes over 45 minutes.) The fractions containing product were concentrated. The residue was taken up in 1 ml_ EtOH, 2 ml_ THF and 1 ml_ H2O, 80 mg (2.00 mmol) of NaOH was added and the solution stirred at 5O0C for 12 hr. The solution was concentrated to 14 volume, added dropwise to 5 ml_ 1.0 N HCI and the resulting solids were filtered, washed with H2O and dried to yield 60 mg (40%) of the title compound as a light pink solid: 1 HNMR (400 MHz, CDCI3) delta 7.59 (d, 1 H, J = 8.1 Hz), 7.42-7.20 (m, 10H), 6.53 (s, 1 H), 5.77 (s, 2H), 2.40 (s, 3H), 2.38 (s, 3H), 1.34 (s, 9H); MS (ESI) m/z 519 (MH+) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Starting from 450 mg of 3-methylthiophenylboric acid obtained from 3-bromothioanisole according to the method of J. Org. Chem., 56, 3763, 1991., 485 mg of the title compound was obtained as pale yellow crystals in the same manner as in Example 52. 1H-NMR (400 MHz, CDCl3) delta 2.53 (3H, s) 3.14 (3H, d, J=4.8 Hz), 3.82 (3H, s), 4.04 (3H, s), 5.15 (1H, br s) ,7.09 (1H, s), 7.13 (1H, s), 7.27 (1H, dt, J=7.6,1.6 Hz), 7.38 (1H, t, J=7.6 Hz), 7.41 (1H, dt, J=7.6,1.6 Hz), 7.53 (1H, t, J=1.6 Hz), 7.60 (1H, t, J=7.6 Hz), 7.68 (1H, dt, J=7.6,1.6 Hz), 7.73 (1H, dt, J=7.6,1.6 Hz), 7.90 (1H, t, J=1.6 Hz). m.p. 195-197 C. MASS 418 (MH+) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
[00151] 5-Bromo-2- {(2S, 3R)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oXo-1- phenylazetidin-2-yl} phenyl acetate (114.5 mg, 0.223 mmol) and 3-thioanisoleboronic acid (48.3 mg, 0.287 mol) were dissolved in toluene (3.0 mL) and ethanol (1.5 mL). A solution of 2.0 M aqueous sodium carbonate (0.215 mL, 0.43 mmol) and solid tetrakis (triphenylphosphine) palladium (O) (14.4 mg, 0.0125 mmol) were added and the vessel was vacuum/nitrogen purged (3x). The reaction was stirred vigorously for 4 h at 60 C under a nitrogen atmosphere and then poured into 0.2 N hydrochloric acid (50 mL), extracted with 1: 1 ethyl acetate-hexane (75 mL), washed with brine (50 mL), dried over sodium sulfate, filtered and concentrated to afford a mixture of products which was used directly in the next step; Rf 0.79 (2: 1 ethyl acetate-hexane) for (3R, 4S)-3- [ (3S)-3- (4- fluorophenyl)-3-hydroxypropyl]-4- [3-hydroxy-3'- (methylthio) biphenyl-4-yl]-1- phenylazetidin-2-one and 0.84 (2: 1 ethyl acetate-hexane) for 4-{(2S, 3R)-3-[(3S)-3-(4- fluorophenyl)-3-hydroxypropyl]-4-oxo-1-phenylazetidin-2-yl}-3'-(methylthio) biphenyl-3- yl acetate. | ||
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In ethanol; water; toluene; at 60℃; for 4h; | 5-Bromo-2-{(2S,3R)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo- l-phenylazetidin-2-yl}phenyl acetate (114.5 mg, 0.223 mmol) and 3- thioanisoleboronic acid (48.3 mg, 0.287 mol) were dissolved in toluene (3.0 mL) and ethanol (1.5 mL). A solution of 2.0 M aqueous sodium carbonate (0.215 mL, 0.43 mmol) and solid tetrakis(triphenylpliosphine)palladium(0) (14.4 mg, 0.0125 mmol) were added and the vessel was vacuum/nitrogen purged (3x). The reaction was stirred EPO <DP n="256"/>vigorously for 4 h at 60 C under a nitrogen atmosphere and then poured into 0.2 N hydrochloric acid (50 rnL), extracted with 1:1 ethyl acetate-hexane (75 mL), washed with brine (50 mL), dried over sodium sulfate, filtered and concentrated to afford a mixture of products which was used directly in the next step; Rf 0.79 (2:1 ethyl acetate-hexane) for (3R,4S)-3-[(3S)-3-(4-fluororhohenyl)-3-hydroxyprorhoyl]-4-[3- hydroxy-3'-(methylthio)biphenyl-4-yl]-l-phenylazetidin-2-one and 0.84 (2:1 ethyl acetate-hexane) for 4-{(2S,3R)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-l- phenylazetidin-2-yl} -3'-(methylthio)biphenyl-3-yl acetate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
164 mg (48%) | With sodium carbonate;palladium diacetate; In 1,2-dimethoxyethane; | Example 54B 9,9,9-trifluoro-N-(4'-(methylsulfanyl)(1,1'-biphenyl)-3-yl)-8-oxononanamide A mixture of Example 54A (308 mg, 0.81 mmol), 4-(methylsulfanyl)phenyl-boronic acid (150 mg, 0.89 mmol), Pd(OAc)2 (9.1 mg, 0.04 mmol), tri-o-tolylphosphine (24.4 mg, 0.08 mmol), and 2M Na2CO3 (2 mL, 2 mmol) in DME (5 mL) was heated to 80 C. for 3 hours, treated with additional Pd (OAc)2 (9 mg), tri-o-tolylphosphine (24 mg), and <strong>[128312-11-8]3-(methylsulfanyl)phenyl-boronic acid</strong> (75 mg), heated for 3 hours, cooled to room temperature, and partitioned between diethyl ether and water. The aqueous phase was extracted with diethyl ether and the combined extracts were washed with brine, dried (Na2SO4), filtered, and concentrated. The concentrate was purified by flash column chromatography on silica gel with 7:3 hexanes/ethyl acetate to provide 164 mg (48%) of the desired product. MS (ESI(-)) m/e 422 (M-H)-; 1H NMR (300 MHz, DMSO-d6) delta9.94 (s, 1H), 7.90 (s, 1H), 7.55 (d, 3H), 7.42-7.22 (m, 4H), 2.86 (t, 2H), 2.49 (s, 3H), 2.33 (t, 2H), 1.68-1.51 (m, 4H), 1.36-1.27 (m, 4H); Anal. Calcd for C22H24NO2F3S: C, 62.39; H, 5.71; N, 3.31. Found: C, 63.18; H, 5.60; N, 2.75. |
164 mg (48%) | With sodium carbonate;palladium diacetate; In 1,2-dimethoxyethane; | Example 54B 9,9,9-trifluoro-N-(4 '-(methylsulfanyl)(1,1'-biphenyl)-3-yl)-8-oxononanamide A mixture of Example 54A (308 mg, 0.81 mmol), 4-(methylsulfanyl)phenyl-boronic acid (150 mg, 0.89 mmol), Pd(OAc)2 (9.1 mg, 0.04 mmol), tri-o-tolylphosphine (24.4 mg, 0.08 mmol), and 2M Na2CO3 (2 mL, 2 mmol) in DME (5 mL) was heated to 80 C. for 3 hours, treated with additional Pd (OAc)2 (9 mg), tri-o-tolylphosphine (24 mg), and <strong>[128312-11-8]3-(methylsulfanyl)phenyl-boronic acid</strong> (75 mg), heated for 3 hours, cooled to room temperature, and partitioned between diethyl ether and water. The aqueous phase was extracted with diethyl ether and the combined extracts were washed with brine, dried (Na2SO4), filtered, and concentrated. The concentrate was purified by flash column chromatography on silica gel with 7:3 hexanes/ethyl acetate to provide 164 mg (48%) of the desired product. MS (ESI(-)) m/e 422 (M-H)-; 1H NMR (300 MHz, DMSO-d6) delta 9.94 (s, 1H), 7.90 (s, 1H), 7.55 (d, 3H), 7.42-7.22 (m, 4H), 2.86 (t, 2H), 2.49 (s, 3H), 2.33 (t, 2H), 1.68-1.51 (m, 4H), 1.36-1.27 (m, 4H); Anal. Calcd for C22H24NO2F3S: C, 62.39; H, 5.71; N, 3.31. Found: C, 63.18; H, 5.60; N, 2.75. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
sodium carbonate; tetrakis(triphenylphosphine)palladium (0); In toluene; | Step (a) Preparation of 4-(4'-Methylsulfanyl-biphenyl-4-yl)-4-oxo-butyric acid, methyl ester In a manner similar to Example 12, Step (b), 4-(methylsulfanyl-phenyl)boronic acid (0.930 g, 0.00553 mol) was allowed to react with 4-(4-bromo-phenyl)-4-oxo-butyric acid, methyl ester (1.356 g, 0.00500 mol) in the presence of tetrakis(triphenylphosphine)palladium(0) (0.162 g, 0.000140 mol) and 2.0 M aqueous sodium carbonate (5.0 mL, 0.010 mol) in toluene (10 mL) to give, after chromatography on silica gel (168 g, 230-400 mesh), eluding with hexanes-acetone (11:1, 20*125 mL; 9:1, 10*125 mL; 6:1, 30*125 mL), 0.405 g of 4-(4'-methylsulfanyl-biphenyl-4-yl)-4-oxo-butyric acid, methyl ester as a white solid; mp 137-140 C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With sodium hydroxide; iodine; magnesium; In tetrahydrofuran; | PREPARATION 101 3-Methylthiophenylboronic Acid A solution of 3-bromothioanisole (10.3 g, 50.9 mmol) in anhydrous tetrahydrofuran (15 ml) was added dropwise to a stirred mixture of magnesium turnings (1.86 g, 75 mmol) and a crystal of iodine under nitrogen. Once the reaction was initiated, the remainder of the solution was added at such a rate as to keep the reaction mixture under reflux. When the addition was complete, the mixture was stirred under reflux for a further 1 hour, allowed to cool to room temperature and then added to a solution of trimethyl borate (5.8 ml, 51 mmol) in anhydrous tetrahydrofuran (25 ml), whilst keeping the internal temperature at about -10 C. The reaction mixture was allowed to warm to about 0 C., stirred for 30 minutes and then quenched with 2M hydrochloric acid. The resulting mixture was extracted with ether, then the combined extracts extracted, in turn, with 2M aqueous sodium hydroxide solution. The combined aqueous extracts were acidified with concentrated hydrochloric acid and extracted with ether. The combined ether extracts were dried (MgSO4) and evaporated under reduced pressure to provide the title compound (7.8 g, 100%) as a white solid. delta(DMSOd6): 2.45 (s,3H), 7.27 (m,2H), 7.54 (m,1H), 7.67 (s,1H), 8.05 (brs,2H), |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | In 1,2-dichloro-ethane; at 60℃; for 6h; | A mixture of <strong>[128312-11-8]3-methylthiophenylboronic acid</strong> (84 mg, 0.5 mmol), Intermediate 1 (90 mg, 0.25 mmol), and glyoxylic acid (0.23 mg, 0.25 mmol) in DCE (1.25 mL), was heated in a pressure tube at 60 C. for 6 h. The mixture was chromatographed (silica gel, 10% methanol in chloroform) to give 126A (86 mg, 69%). LC-MS m/z: 540.3 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With caesium carbonate;bis(1-adamantylamine)palladium(0); In 1,4-dioxane; at 80℃; for 4h; | 5-Bromo-2- {(2S,3R)-3-[(3S)-3- [tert-buryl(dimethyl)silyl]oxy} -3-(4- fluorophenyl)propyl]-4-oxo-l-phenylazetidin-2-yl}phenyl acetate (850 mg, 1.36 EPO <DP n="294"/>mmol) and 4-thioanisoleboronic acid (252 mg, 1.50 mmol) were dissolved in dioxane (13.6 mL). Cesium carbonate (882 mg, 2.71 mmol) and solid bis(l- adamantylamine)palladium(O) (113 mg, 0.21 mmol) were added and the vessel was vacuum/nitrogen purged (3x). The reaction was stirred vigorously for 4 h at 80 0C under a nitrogen atmosphere and then cooled and reacted with acetic anhydride (0.70 mL, 7.3 mmol) and 4-dimethylammo-pyridine (185.6 mg, 1.52 mmol). After 15 min, the mixture was poured into 1.0 N hydrochloric acid (60 mL), extracted with 1:1 ethyl acetate-hexane (60 mL), washed with brine (60 mL), dried over sodium sulfate, filtered, concentrated and purified by chromatography (40 g silica gel, 5% to 50% ethyl acetate-hexane) to afford 4-{(2S,3R)-3-[(3S)-3-[tert-butyl(dimethyl)silyl]oxy}- 3-(4-fluorophenyl)propyl]-4-oxo- 1 -phenylazetidin-2-yl} -4'-(methylthio)biphenyl-3-yl acetate (478 mg, 52% yield) as a white foam; Rf 0.41 (1:4 ethyl acetate-hexane). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
A mixture of phenylamino-oxopropanoic acid in PPA (0.6M) was stirred at 130 C for 2 h. After this time the reaction was cooled to rt and treated with 2M aqueous sodium hydroxide until a precipitate formed. The precipitate was filtered and washed with IM aqueous sodium hydroxide and dried under vacuum to give substituted quinoline diols.; Procedure DA mixture of the quinoline diol (1 eq) and phosphorus oxy chloride (10 eq) was heated at 100 C for 2 h. After this time the reaction was cooled to rt and evaporated under reduced pressure. The resulting brown residue was taken up in DCM and washed with water. The separated organic layer was dried over MgSO4, filtered and evaporated under reduced pressure. The product was then purified by column chromatography (using a 9 to 1 mixture of hexanes and EtOAc as eluent) to give the substituted dichloroquino lines.; 2,4-Dichloro-7-fluoro-3-methylquinoline and 2,4-dichloro-5-fluoro-3-methyl quinolinePrepared according to procedure D using 7-fluoro-3-methylquinoline-2,4-diol and 5-fluoro-3-methylquinoline-2,4-diol (14.0 g, 72 mmol) to give a mixture of 2,4- dichloro-7-fluoro-3-methylquinoline and 2,4-dichloro-5-fluoro-3-methyl quinoline as a white solid. Mass Spectrum (ESI) m/e = 230 (M + 1).; 4-Chloro-7-fluoro-3-methyl-2-(3-(methylthio)phenyl)quinoline2,4-Dichloro-7-fluoro-3-methylquinoline (in a mixture with the 5-F regioisomer) (390 mg, 1.7 mmol) (described herein), 3-(methylthio)phenylboronic acid (370 mg, 2.2 mmol), tetrakis(triphenylphosphine)palladium(o) (98 mg, 0.085 mmol), and sodium carbonate (539 mg, 5.1 mmol) in acetonitrile (4.0 mL) and water (1.0 mL) were stirred and heated in a microwave at 100 C for 60 min. The reaction mixture was then partitioned between EtOAc and water and washed with brine. The organic layer was dried (MgSO4), concentrated, and purified by column chromatography to afford (in order of elution) 4-chloro-7-fluoro-3-methyl-2-(3- (methylthio)phenyl)quinoline and 4-chloro-5 -fluoro-3 -methyl-2-(3 -(methylthio)- phenyl)quinoline as white powders. Mass Spectrum (ESI) m/e = 318 (M + 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium phosphate; In 1,4-dioxane; water; at 95℃; for 24h;Inert atmosphere; | General procedure: To an array of vials containing a solution of aryl triflate 10 (30 mg, 1 equiv) in 1,4-dioxane (1 mL)was added various aryl boronic acids (1.1 equiv), [1,10-bis(diphenylphosphino)ferrocene] dichloropalladium(II) (0.03 equiv) and aqueous K3PO4 (3 equiv). The reaction mixtures were degassed with nitrogen and heated at 95 C for 24 h. The reaction mixtures were cooled to room temperature and were filtered through a short pad of silica. The filtrates were evaporated in a Genevac. To the resulting array of crude aldehyde was added a suspension of sodium borohydride (1 equiv) in anhydrous ethanol (1 mL). The reaction mixtures were stirred at room temperature for 4 h. The solvents were evaporated in a Genevac and the residues were purified by reverse phase preparative HPLC. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
49.1% | With palladium diacetate; potassium carbonate; triphenylphosphine; In ethanol; toluene; at 60℃; for 12h;Inert atmosphere; | General procedure: The general procedure for the preparation of N-(3-phenyl)-2,2-dichloroacetamide heterocyclic derivatives was as follows. A mixture of 0.2mmol 2,2-dichloro-N-(3,5-diiodo-phenyl)acetamide, 0.6 mmol substituted phenylboronic acid, 0.8 mmol K2CO3, 0.16mmol triphenyl phosphine, and 0.04 mmol palladium acetate were stirred in 3 mL toluene and 3 mL ethanol at 60? under a argon atmosphere. The progress of the reaction was monitored by TLC (petroleum ether/ethyl acetate). After the reaction finished, the reaction mixture was filtered. The filtrate was concentrated to dryness and subjected to flash column chromatography (silica gel), eluting with petroleum ether/ethyl acetate, to give N-([1,1':3',1''-terphenyl]-5'-yl)-2,2-dichloroacetamide derivatives. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
40% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; caesium carbonate; In 1,4-dioxane; water; at 100℃; for 16h;Inert atmosphere; | To a mixture of 3-(4-iodo-3-methyl-1H-pyrazol-1-yl)pyridine (100 mg, 0.7042 mmol) and <strong>[128312-11-8](3-(methylthio)phenyl)boronic acid</strong> (141.9 mg, 0.845 mmol) in 1-4 dioxane:water (2:1) (4.5 mL) was added cesium carbonate (504.7 mg, 1.5492 mmol), purged with Argon gas for 5-10 min then PdCl2(dppf) (51.5 mg, 0.0704 mmol) was added again purged with Argon gas for 5-10 min. The reaction mixture was then heated at 100 C. for 16 hrs and cooled to room temperature then filtered, diluted with ethyl acetate and washed with H2O. The organic layer was concentrated under reduced pressure. The residue was purified by Prep HPLC to afford a grey solid (78 mg, 40%): mp 104-109 C.; 1H NMR (300 MHz, CDCl3) delta 8.99 (d, J=2.5 Hz, 1H), 8.53 (dd, J=4.7, 1.3 Hz, 1H), 8.06 (ddd, J=8.3, 2.6, 1.5 Hz, 1H), 8.00 (s, 1H), 7.37 (m, 3H), 7.23 (m, 2H), 2.53 (s, 3H), 2.49 (s, 3H); ESIMS m/z 281 ([M+H]+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With bis-triphenylphosphine-palladium(II) chloride; potassium carbonate; In 1,4-dioxane; water; at 150℃; for 0.5h;Microwave irradiation; | General procedure: To a solution of 7 (55.9 mg, 0.107 mmol) in dioxane (1.1 mL) and water (0.5 mL) was added 3-methylphenylboronic acid (21.9 mg, 0.161 mmol), potassium carbonate (44.5 mg, 0.322 mmol), dichlorobis(triphenylphosphine)palladium (3.8 mg, 0.00537 mmol), and the mixture was heated at 150 C under microwave for 30 min. The reaction mixture was partitioned between AcOEt and water. The organic layer was washed water, brine, dried with Na2SO4, and evaporated. The residue was purified by silicagel chromatography (AcOEt : MeOH = 10 : 1) to obtain free form of 9. This was dissolved in dioxane (0.5 mL) and 4M hydrogen chloride in dioxane (0.081 ml, 0.322 mmol) was added. After the evaporation of the solvent, the residue was solidified with AcOEt. The solid was filtered and washed with AcOEt to give 9 (21.5 mg, 0.0584 mmol, 54 %) as a colorless solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In N,N-dimethyl-formamide; at 90℃; for 3h;Inert atmosphere; | A stirred solution of compound 35 (1.6 g, 4.0 mmol) and <strong>[128312-11-8](3-(methylthio)phenyl)boronic acid</strong> (1.06 g, 6.0 mmol) in DMF (20 mL) was degassed with argon. Tetrakis(triphenylphosphine)palladium(0) (462 mg, 0.4 mmol) was added and the reaction again degassed for 30 min. Sodium carbonate (1.06 g, 10.0 mmol) was added to the reaction mixture, and the reaction was again degassed with argon for another 30 min. The reaction mixture was heated to 90 C for 3h. Solvent was removed, the reaction mixture diluted with water (30 mL) and extracted with ethyl acetate (50 mL X 3). The combined organic layer was washed with saturated brine, dried over sodium sulphate and concentrated. The crude reaction mixture was purified by column chromatography using 30%> ethyl acetate in hexane to afford 35b (1.5 g, 99%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In N,N-dimethyl-formamide; at 90℃; for 3h;Inert atmosphere; | A mixture of compound 45 (1.25 g, 3.42 mmol) and <strong>[128312-11-8](3-(methylthio)phenyl)boronic acid</strong> (1.15 g, 6.84 mmol) in DMF (50 mL) was degassed with argon for 30 min. To the mixture tetrakis(triphenylphosphine)palladium(0) (390 mg, 0.34 mmol) was added, degassed for 30 min followed by sodium carbonate (0.91 g, 8.56 mmol). The reaction was again degassed with argon for 30 min and heated to 90 C for 3h. After completion of reaction, solvent was removed under reduced pressure and the reaction mixture diluted with water (30 mL). The mixture was extracted with ethyl acetate (50 mL X 3) and combined organic layer was washed with saturated brine (50 mL X 2), dried over sodium sulphate and concentrated under reduced pressure. Crude compound was purified by column chromatography using 5% ethyl acetate in n-hexane as an eluent to afford compound 46 (1 g, 71%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.33 g | With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; cesium fluoride; In 1,4-dioxane; at 90℃; for 3.5h; | Preparation example 59A mixture of Present compound (T057) 0.30 g, 3-methyl- thiophenylboronic acid 0.26 g, cesium fluoride 0.42 g, [1,1? -bis(diphenylphosphino) ferrocene]palladium(II)dichloride dichioromethane adduct 0.06 g and dioxane 6 mL was stirred at 90C for three and a half hours. After cooling the reaction mixtures, the mixtures were filtered off and the filtrates were concentrated under reduced pressure. The resulting residues were subjected to asilica gel column chromatography to give 2-[1-(4,5- dihydro-4-methyl-5-oxo-1H-tetrazole-l-yl) -3-methylphenyl-2- yl]methyloxy}-4- (3-methylthiophenyl)thizole (hereinafter, referred to as ?Present compound (T059) I?) 0.33 g.?H NMR (CDC13) 6: 2.54(3H, 5), 2.58(3H, s), 3.58(3H, s), 5.61(2H, s), 6.84(1H, s), 7.19-7.21(1H, rn), 7.25-7.28(1H, m), 7.31(1H, t, J=7.7Hz), 7.40-7.45(2H, rn), 7.52-7.54(1H,m) , 7.70(1H, t, J=1.7Hz) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With potassium phosphate monohydrate; XPhos; palladium diacetate; In ethanol; water; at 70℃; for 1h;Microwave irradiation; Inert atmosphere; | General procedure: (method PI) To a dry microwave vial containing the boronic acid or boron pinacol ester (1.0 eq), XPhos (0.06 eq) and potassium triphosphate monohydrate (2.0 eq) under argon atmosphere, was added a solution of tert-butyl (2-bromoallyl)(methyl)carbamate (0.9 eq) in ethanol. H20 was added and the mixture was degassed using nitrogen gas for 10 mins. Palladium (II) acetate catalyst (2 mol%) was subsequently added and the mixture was further degassed for 5 mins before the sealed reaction mixture was heated under microwave condition at 70 C for 1 h. When the reaction was completed, the solvents were removed in vacuo and the residue was partitioned between ethyl acetate and H20. The organic layer was washed twice with H20 and dried with MgS04. After filtration, the solvent was removed in vacuo to afford the crude product which was further purified by column chromatography. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
20 mg | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; ethanol; at 88℃; for 2h; | 5-(3-Bromo-pyridin-5-yl)-1-(2,4-difluoro-phenyl)-3-pentafluoroethyl-4,5-dihydro-1H-pyrazole (50.0 mg, 0.11 mmol) prepared in Step 4 of Preparation 10, 3-(methylthio)phenylboronic acid (28.0 mg, 0.17 mmol), Pd(PPh3)4 (12.7 mg, cat.) and a 2N sodium carbonate solution (550.0 uL) were added to a mixed solvent of ethanol (600.0 uL) and 1,2-dimethoxyethane (2.0 mL). The reaction mixture was stirred at 88 C. for 2 hours and then filtered through celite pad. A saturated solution of ammonium chloride was added to the filtrate, which was then extracted with ethyl acetate three times. The combined extract was washed with brine, dried on anhydrous magnesium sulfate, and then concentrated under reduced pressure to give a yellow liquid residue. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/6) to give 20.0 mg of the titled compound as a white liquid. (0582) 1H NMR (400 MHz, CDCl3) 8.70 (s, 1H), 8.42 (s, 1H), 7.61 (s, 1H), 7.42-7.37 (m, 2H), 7.30-7.26 (m, 2H), 7.20 (d, 1H), 6.78 (t, 1H), 6.69 (t, 1H), 5.68 (dd, 1H), 3.73 (dd, 1H), 3.21 (dd, 1H), 2.52 (s, 3H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35 mg | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; ethanol; at 85℃; for 3h; | 5-(4-Bromo-pyridin-2-yl)-1-(2,4-difluoro-phenyl)-3-pentafluoroethyl-4,5-dihydro-1H-pyrazole (50.0 mg, 0.11 mmol) prepared in Step 4 of Preparation 11, 3-(methylthio)phenylboronic acid (28.0 mg, 0.17 mmol), Pd(PPh3)4 (12.8 mg, cat.) and a 2N sodium carbonate solution (550.0 uL) were added to a mixed solvent of ethanol (550.0 uL) and 1,2-dimethoxyethane (1.2 mL). The reaction mixture was stirred at 85 C. for 3 hours and then filtered through celite pad. A saturated solution of ammonium chloride was added to the filtrate, which was then extracted with ethyl acetate three times. The combined extract was washed with brine, dried on anhydrous magnesium sulfate, and then concentrated under reduced pressure to give a yellow liquid residue. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/6) to give 35.0 mg of the titled compound as a white liquid. (0603) 1H NMR (400 MHz, CDCl3) 8.55 (d, 1H), 7.39-7.29 (m, 6H), 7.23 (D, 1H), 6.78-6.67 (m, 2H), 5.73 (dd, 1H), 3.66 (Dd, 1H), 3.35 (dd, 1H), 2.51 (s, 3H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
15 mg | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; ethanol; at 85℃; for 3h; | 5-(2-Bromo-pyridin-4-yl)-1-(2,4-difluoro-phenyl)-3-pentafluoroethyl-4,5-dihydro-1H-pyrazole (50.0 mg, 0.11 mmol) prepared in Step 4 of Preparation 12, 3-(methylthio)phenylboronic acid (28.0 mg, 0.17 mmol), Pd(PPh3)4 (12.8 mg, cat.) and a 2N sodium carbonate solution (550.0 uL) were added to a mixed solvent of ethanol (550.0 uL) and 1,2-dimethoxyethane (1.2 mL). The reaction mixture was stirred at 85 C. for 3 hours and then filtered through celite pad. A saturated solution of ammonium chloride was added to the filtrate, which was then extracted with ethyl acetate three times. The combined extract was washed with brine, dried on anhydrous magnesium sulfate, and then concentrated under reduced pressure to give a yellow liquid residue. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/6) to give 15.0 mg of the titled compound as a white liquid. (0626) 1H NMR (400 MHz, CDCl3) 8.58 (d, 1H), 7.80 (s, 1H), 7.62 (d, 1H), 7.47 (s, 1H), 7.44-7.35 (m, 2H), 7.30 (d, 1H), 6.99 (d, 1H), 6.79 (t, 1H), 6.68 (m, 1H), 5.63 (dd, 1H), 3.71 (dd, 1H), 3.16 (dd, 1H), 2.52 (s, 3H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
20 mg | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate; In 1,4-dioxane; water; at 90℃; for 2h; | 5-(4-Bromo-2-fluoro-phenyl)-1-(2-chloro-phenyl)-3-[di-(trifluoromethyl)-hydroxy-methyl]-4,5-dihydro-1H-pyrazole (50.0 mg, 0.10 mmol) prepared in Step 5 of Preparation 19, <strong>[128312-11-8]3-methylthiophenylboronic acid</strong> (17.8 mg, 0.11 mmol), potassium carbonate (40.0 mg, 0.29 mmol), and Pd(dppf)Cl2 (7.0 mg, cat.) were added to a mixed solvent of 1,4-dioxane (750.0 uL) and distilled water (150.0 uL). The reaction mixture was stirred for 15 minutes, additionally at 90 C. for 2 hours, and then ethyl acetate was added thereto. The reaction mixture was washed with distilled water and brine, dried on anhydrous magnesium sulfate, and then concentrated under reduced pressure to give a yellow liquid residue. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/4) to give 20.0 mg of the titled compound as a yellow liquid. (0860) 1H NMR (400 MHz, CDCl3) 7.32 (d, 2H), 7.29-7.21 (m, 6H), 7.14-7.10 (m, 2H), 6.98 (t, 1H), 6.14 (dd, 1H), 4.94 (s, 1H), 3.65 (dd, 1H), 3.21 (dd, 1H), 2.50 (s, 3H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
6.1 mg | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; ethanol; at 88℃; for 2h; | 5-(4-Bromo-phenyl)-1-(2,4-difluoro-phenyl)-3-[di-(trifluoromethyl)-hydroxy-methyl]-4,5-dihydro-1H-pyrazole (50.0 mg, 0.10 mmol) prepared in Step 2 of Preparation 22, 3-(methylthio)-phenylboronic acid (25.0 mg, 0.15 mmol), Pd(PPh3)4 (11.5 mg, cat.), ethanol 0.5 mL and a 2N sodium carbonate solution (0.5 mL) were added to 1,2-dimethoxyethane (2.0 mL). The reaction mixture was stirred at 88 C. for 2 hours and then filtered through celite pad. A saturated solution of ammonium chloride was added to the filtrate, which was then extracted with ethyl acetate three times. The combined extract was washed with brine, dried on anhydrous magnesium sulfate, and then concentrated under reduced pressure to give a yellow liquid residue. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/10) to give 6.1 mg of the titled compound as a yellow liquid. (0907) 1H NMR (400 MHz, CDCl3) 7.46 (d, 2H), 7.40 (s, 1H), 7.34-7.20 (m, 6H), 6.76-6.69 (m, 2H), 5.62 (dd, 1H), 4.87 (s, 1H), 3.63 (dd, 1H), 3.17 (dd, 1H), 2.51 (s, 3H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
9.2 mg | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; ethanol; at 88℃; for 4h; | 5-(5-Bromo-thiophen-2-yl)-1-(2-chloro-phenyl)-3-[di-(trifluoromethyl)-hydroxy-methyl]-4,5-dihydro-1H-pyrazole (100.0 mg, 0.20 mmol) prepared in Step 5 of Preparation 23, <strong>[128312-11-8]3-methylthiophenylboronic acid</strong> (50.4 mg, 0.30 mmol), Pd(PPh3)4 (23.0 mg, 0.02 mmol), and a 2N sodium carbonate solution (1.0 mL) were added to a mixed solvent of 1,2-dimethoxyethane (2.0 mL) and ethanol (1.0 mL). The reaction mixture was stirred at 88 C. for 4 hours and then ethyl acetate was added thereto. The reaction mixture was washed with distilled water and brine, dried on anhydrous magnesium sulfate, and then concentrated under reduced pressure to give a yellow liquid residue. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/5) to give 9.2 mg of the titled compound as a yellow liquid. (0972) 1H NMR (400 MHz, CDCl3) 7.30 (d, 2H), 7.25-7.11 (m, 5H), 7.08 (t, 1H), 6.98 (s, 1H), 6.76 (s, 1H), 6.19 (dd, 1H), 4.90 (s, 1H), 3.62 (dd, 1H), 3.37 (dd, 1H), 2.48 (s, 3H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
3.7 mg | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; ethanol; at 90℃; for 2h; | 1-(4-Bromo-phenyl)-5-(2-chloro-phenyl)-3-[di-(trifluoromethyl)-hydroxy-methyl]-4,5-dihydro-1H-pyrazole (50.0 mg, 0.10 mmol) prepared in Step 5 of Preparation 24, <strong>[128312-11-8]3-methylthiophenylboronic acid</strong> (25.1 mg, 0.15 mmol), Pd(PPh3)4 (11.5 mg, 0.01 mmol), and a 2N sodium carbonate solution (0.5 mL) were added to a mixed solvent of 1,2-dimethoxyethane (2.0 mL) and ethanol (0.5 mL). The reaction mixture was stirred at 90 C. for 2 hours and then ethyl acetate was added thereto. The reaction mixture was washed with distilled water and brine, dried on anhydrous magnesium sulfate, and then concentrated under reduced pressure to give a yellow liquid residue. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/10) to give 3.7 mg of the titled compound as a yellow liquid. (0985) 1H NMR (400 MHz, CDCl3) 7.44-7.38 (m, 3H), 7.32 (s, 1H), 7.27-7.22 (m, 4H), 7.16 (t, 2H), 6.96 (d, 2H), 5.89 (dd, 1H), 4.86 (s, 1H), 3.80 (dd, 1H), 2.93 (dd, 1H), 2.50 (s, 3H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
15 mg | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; ethanol; at 90℃; for 3h; | 5-(5-Bromo-thiophen-2-yl)-1-(2,4-difluoro-phenyl)-3-pentafluoroethyl-4,5-dihydro-1H-pyrazole (50.0 mg, 0.11 mmol) prepared in Step 8 of Preparation 13, 3-(methylthio)phenylboronic acid (28.0 mg, 0.17 mmol), Pd(PPh3)4 (12.5 mg, cat.) and a 2N sodium carbonate solution (500.0 uL) were added to a mixed solvent of ethanol (500.0 uL) and 1,2-dimethoxyethane (2.0 mL). The reaction mixture was stirred at 90 C. for 3 hours and then filtered through celite pad. A saturated solution of ammonium chloride was added to the filtrate, which was then extracted with ethyl acetate three times. The combined extract was washed with brine, dried on anhydrous magnesium sulfate, and then concentrated under reduced pressure to give a yellow liquid residue. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/6) to give 15.0 mg of the titled compound as a white liquid. (0645) 1H NMR (400 MHz, CDCl3) 7.44-7.27 (m, 4H), 7.15 (d, 1H), 6.98 (s, 1H), 6.82 (s, 1H), 6.78-6.74 (m, 2H), 5.83 (d, 1H), 3.62 (dd, 1H), 3.34 (dd, 1H), 2.50 (s, 3H) |
Tags: 128312-11-8 synthesis path| 128312-11-8 SDS| 128312-11-8 COA| 128312-11-8 purity| 128312-11-8 application| 128312-11-8 NMR| 128312-11-8 COA| 128312-11-8 structure
[ 98546-51-1 ]
4-(Methylthio)phenylboronic acid
Similarity: 0.97
[ 870718-05-1 ]
(3-(Ethylthio)phenyl)boronic acid
Similarity: 0.89
[ 352526-01-3 ]
(3-Mercaptophenyl)boronic acid
Similarity: 0.88
[ 98546-51-1 ]
4-(Methylthio)phenylboronic acid
Similarity: 0.97
[ 870718-05-1 ]
(3-(Ethylthio)phenyl)boronic acid
Similarity: 0.89
[ 352526-01-3 ]
(3-Mercaptophenyl)boronic acid
Similarity: 0.88
[ 168618-42-6 ]
(2-(Methylthio)phenyl)boronic acid
Similarity: 0.86
[ 98546-51-1 ]
4-(Methylthio)phenylboronic acid
Similarity: 0.97
[ 870718-05-1 ]
(3-(Ethylthio)phenyl)boronic acid
Similarity: 0.89
[ 168618-42-6 ]
(2-(Methylthio)phenyl)boronic acid
Similarity: 0.86
[ 2096332-50-0 ]
(3-(Isopropylthio)phenyl)boronic acid
Similarity: 0.84
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :